Trial Number
909-19
Conditions
Acute Lymphoblastic Leukemia (ALL), Leukemia
Participant Age Range
1 year to 21 years
Participant Gender
Any
Enrolling Participants
Yes
Overview
“AALL1631: International Phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones”
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia.